Recombinant Human CEMIP2 Protein，His

CEMIP2, or Cell Migration-Inducing and Hyaluronan-Binding Protein 2, is a member of the KIAA1199 gene family, which has garnered attention due to its role in various cellular processes, including cell migration, proliferation, and extracellular matrix remodeling. Research indicates that CEMIP2 is involved in the regulation of hyaluronic acid metabolism, a key component of the extracellular matrix, which contributes to tissue hydration and cell signaling. Elevated levels of CEMIP2 have been implicated in several pathological conditions, including cancer, where it appears to facilitate tumor progression and metastasis by promoting epithelial-mesenchymal transition (EMT) and enhancing cell migratory properties. Moreover, CEMIP2's interaction with inflammatory signaling pathways highlights its potential involvement in chronic inflammatory diseases. The study of CEMIP2 as a recombinant protein aims to elucidate its functional roles and molecular mechanisms. By producing CEMIP2 in vitro, researchers can investigate its biochemical properties and interactions with other cellular components, paving the way for therapeutic applications. Understanding CEMIP2's mechanisms could lead to novel strategies for targeting tumor metastasis and other diseases characterized by excessive cell migration and matrix remodeling. Thus, CEMIP2 represents a promising candidate for further research in fields ranging from oncology to regenerative medicine, highlighting the importance of this protein in both health and disease contexts.